Looking back on the year 2023, this note aims to give an update on the state of play in Chinese merger control. In particular, it looks at how merger control has evolved since China’s main antitrust statute – the Anti-Monopoly Law (“AML”) – was amended for the first time in summer 2022. I will look…

Legislative developments Following the amendment of the Anti-Monopoly Law (AML) in 2022, the State Administration for Market Regulation (SAMR) unveiled a series of departmental regulations in March 2023: (1) Provisions on Prohibiting Monopoly Agreements; (2) Provisions on Prohibiting Abuse of Dominant Market Position; (3) Provisions on the Examination of Concentrations of Undertakings; (4) Provisions on…

On 29 May 2023, China’s antitrust authority – the State Administration for Market Regulation (“SAMR”) – published the decision against Zizhu Pharma on its webpage.  The company was fined by SAMR’s Beijing branch for engaging in resale price maintenance (“RPM”), the antitrust lingo for describing a supplier forcing its distributors to follow minimum resale prices. The Zizhu Pharma decision…

Introduction On 24 March 2023, China’s antitrust authority – the State Administration for Market Regulation (“SAMR”) – issued four regulations implementing the recently amended Anti-Monopoly Law (“AML”): Regulation Prohibiting Monopoly Agreements (“Agreements Regulation”); Regulation Prohibiting Conduct Abusing a Dominant Market Position (“Abuse of Dominance Regulation”); Regulation on the Review of Concentrations between Business Operators (“Merger…

The year of 2022 was marked by the first amendment of China’s Anti-Monopoly Law (AML) since its entry into force in 2008 and the gradual shift of the enforcement focus towards the objectives of the unified national market.   Amendment of the Anti-Monopoly Law and other legislative developments First, the AML amendment incorporated the “fair…

Yesterday, on 29 August 2022, clearance for the FAW/Refire joint venture transaction was announced on one of the websites of the Chinese antitrust authority – i.e., the State Administration for Market Regulation (“SAMR”).  That transaction marks the first case where Chinese merger review was handled by a local SAMR office. The foundations to this delegation…

The year of 2021 was very dynamic for China’s competition law. It was marked by the adoption of the new competition legislation, accelerating antitrust enforcement in the digital economy, breaking new records in terms of fines and merger prohibitions, re-organization of the competition authority, and promotion of stronger antitrust compliance programs.   Anti-monopoly legislation and…

On 18 November 2021, the China competition authority State Administration for Market Regulation (“SAMR”) released the decision that the acquisition of Illinois Tool Works Inc. (”ITW“) over MTS Systems Corporation (“MTS”) is conditionally approved (the “Decision”) [1]. It is the third merger case cleared with remedies by the SAMR in 2021. But what is eye-catching…

Chinese antitrust is going through what are likely the most important changes since its inception: an amendment of the Anti-Monopoly Law and the establishment of a new enforcement body.   Anti-Monopoly Law amendment On 23 October 2021, the Standing Committee of the National People’s Congress – China’s legislature – published a draft revision of the…